Apical hypertrophic cardiomyopathy can be controlled by systemic therapy with medications such as propranolol, but it is not curable, and increased cardiac loading, among other things, may lead to recurrence. The pathogenesis of apical hypertrophic cardiomyopathy has not been proven, but the disease is a combination of factors and is more common in men. Apical hypertrophic cardiomyopathy progresses slowly, with typical manifestations occurring in middle age, often causing chest tightness, dizziness, chest pain, etc., and a few people have no conscious symptoms. It cannot be cured, and recurrence can be caused by high blood pressure, strenuous exercise, and alcohol abuse. Generally after systematic treatment the condition can be well controlled and complications reduced. It can be treated with drugs such as beta-blockers like propranolol. Such drugs may cause side effects such as dizziness and hypotension, and are contraindicated in allergy sufferers and patients with bronchial asthma, cardiogenic shock and sinus bradycardia. It can also be treated with surgery. The diagnosis of apical hypertrophic cardiomyopathy requires avoidance of strenuous exercise and active treatment to avoid exacerbation of the condition, complications leading to poor prognosis or even sudden death, and the use of medication should be preceded by consultation with a doctor.